Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

About Infectex

Developer of drugs for infectious diseases. The company develops drugs for the treatment of tuberculosis (TB). The drug is a second-generation ethambutol (EMB) analog, which inhibits mycobacterium tuberculosis cell growth by interfering with cell wall synthesis.

Infectex Headquarter Location

7/10 building 3 Bolshaya Polyanka street

Moscow, 119180,

Russian Federation

7 495 411 6992

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.